Exchange Traded Concepts to Close and Liquidate Corbett Road Tactical Opportunity ETF
- Dollar, stocks slip as rate cut expectations fade quickly
- Capital One (COF) to acquire Discover Financial (DFS) in all-stock deal
- China unexpectedly cuts 5-year loan prime rate, 1-year LPR left unchanged
- UBS lifts S&P 500 year-end target to 5,400
- Home Depot (HD) shares slide on Q4 comparable sales dip
The Fund will be closed to orders for new creation units on
In anticipation of the liquidation, the Fund will be managed in a manner intended to facilitate its orderly liquidation, such as by raising cash or making investments in other highly liquid assets. As a result, in preparation for the liquidation, all or a portion of the Fund may not be invested in a manner consistent with its stated investment strategy, which may prevent the Fund from achieving its investment objective.
On or about the Liquidation Date, the Fund will liquidate its assets and distribute cash pro rata to all remaining shareholders. This distribution is a taxable event. In addition, this payment to shareholders will include accrued capital gains and dividends, if any. As calculated on the Liquidation Date, the Fund's net asset value will reflect the costs of closing the Fund. Once the distributions are complete, the Fund will terminate.
If you would like additional information, please call: (866) 983-0885 or visit: www.corbettroadfunds.com.
Fund shareholders of record as of the record date are eligible to receive dividends from the liquidation distribution. The Fund will liquidate and pay dividends to shareholders of record on the pay date.
Shares are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. NAVs are calculated using prices as of
Carefully consider the Funds' investment objectives, risk factors, charges and expenses before investing. This and additional information can be found in the Fund's prospectus and Summary Prospectus, which may be obtained by visiting https://corbettroadfunds.com/investor-materials. Read the prospectus and Summary Prospectus carefully before investing.
Foreside Fund Services, LLC, distributor.
Investing involves risk, including possible loss of principal. The Fund is non-diversified; to the extent the Fund's investments are concentrated in or have significant exposure to a particular issuer, industry or group of industries, or asset class, the Fund may be more vulnerable to adverse events affecting such issuer, industry or group of industries, or asset class than if the Fund's investments were more broadly diversified. Issuer-specific events, including changes in the financial condition of an issuer, can have a negative impact on the value of the Fund.
The Fund may invest in ETFs that hold equity securities and, under certain market conditions, in ETFs that hold debt securities. The Fund is subject to the risks associated with the ETFs' investments, including the possibility that the value of the instruments held by an ETF could decrease. The Fund's exposure to a particular risk will be proportionate to the Fund's overall allocation and each ETF's asset allocation. In addition, by investing in the Fund, shareholders indirectly bear fees and expenses charged by the ETFs in addition to the Fund's direct fees and expenses. As a shareholder in another ETF, the Fund bears its proportionate share of the ETF's expenses, potentially subjecting Fund shareholders to duplicative expenses.
There is no guarantee that the Sub-Adviser's allocation techniques and decisions will produce the desired results. Investments in non-
A smaller fund is subject to the risk that its performance may not represent how the fund is expected to or may perform in the long term. In addition, smaller funds may not attract sufficient assets to achieve investment and trading efficiencies.
Shares are bought and sold at market price not net asset value (NAV) and are not individually redeemed from the Fund. Performance is based on the official closing price from the Exchange and does not represent the return you would receive if you traded at other times.
SOURCE Exchange Traded Concepts, LLC
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- TECVAYLI® (teclistamab-cqyv) biweekly dosing approved by the U.S. FDA for the treatment of patients with relapsed or refractory multiple myeloma
- ALFA reports 4Q23 EBITDA of US $282 million and 2023 EBITDA of US $1.4 billion
- GFL Environmental Reports Fourth Quarter and Full Year 2023 Results; Provides Full Year 2024 Guidance
Create E-mail Alert Related CategoriesPRNewswire, Press Releases
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!